EMPOWERING PHYSICIANS WITH EVIDENCE-BASED CONTENT
 

Home > Browse Topics

<< Bites and Stings – Snakes, Spiders, and Scorpions in the United States

Case Conclusions

The snake responsible for this envenomation was a Southern Pacific Rattlesnake (Crotalus viridis helleri). You controled the patient's pain with opioids and began treatment with CroFab®. After the initial dose of antivenom, the child's thrombocytopenia improved and the swelling stopped progressing. He was admitted to the hospital for further observation and continuing antivenom therapy. The fasciculations gradually resolved and the child was kept comfortable with opioids and benzodiazepines. The next day, after finishing the antivenom protocol, the patient's pain was well controlled with opioids and the swelling improved. There were no further changes on his morning laboratory values . The patient was discharged home on oral pain medications, with a warning that the swelling may take several weeks to completely resolve. You told his parents to follow-up with his pediatrician for reexamination and recheck of his blood counts and coagulation studies.

The implicated snake in this vignette is the coral snake, an elapid. The venom in coral snakes is a neurotoxin causing respiratory failure. In this case, the child was immediately intubated, placed on ventilatory support, and transferred to the intensive care unit. Attempts were made by the physicians to locate Antivenin (Micrurus fulvius) without success and the decision was made to manage the child with supportive care and antivenom therapy was not pursued further. After two days, the effects of the neurotoxic venom began to wear off and the patient started to have spontaneous respirations. By day four, the patient was extubated and maintained her own respirations, though she had some residual generalized weakness. She was discharged home by day five of hospitalization with instructions to her parents to follow-up with her general physician.

The patient's symptoms are caused by α-latrotoxin, a potent neurotoxin. You immediately began treating this patient with opioids and benzodiazepines in order to control her pain and anxiety. Your hospital pharmacy had latrodectus antivenom available. However, after discussing the risks and benefits of the treatment options, the family declined antivenom therapy. You admitted the child to the observation unit on opioids and benzodiazepines. In the morning, her pain was much improved and she was discharged home on oral pain medications.

Based on the patient's presentation, he was likely
stung by Centruroides exilicauda, the bark scorpion. As you were speaking with the family, your staff members called the Arizona State University to inquire if there were any units of the scorpion antivenom still available. They were told that the antivenom stores are now expired and can not be used. You started the patients on opioids and benzodiazepines in order to control his pain and anxiety as well as other supportive measures, such as intravenous fluids. He responded to the treatment by becoming less anxious and less tachycardic. You admitted him to the pediatric ward where, over the next two days, he continued to require opioids and benzodiazepines. His fasciculations and drooling gradually improved. On day three, the patient's pain had greatly diminished and he was discharged home on oral pain medications with instructions to the parents to follow up with his pediatrician.

Other Articles Similar To This One:

CME Budget Ending? 20% Off all CME Resources!

EMplify, the new Emergency Medicine Practice podcast, is now available

 

About EB Medicine:

Products:

Accredited By:

ACCME ACCME
AMA AMA
ACEP ACEP
AAFP AAFP
AOA AOA
AAP AAP

Endorsed By:

AEMAA AEMAA
HONcode HONcode
STM STM

 

Last Modified: 06/27/2017
© EB Medicine